ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 0978

Associations of Fire Smoke and Other Pollutants with Incident Rheumatoid Arthritis and Rheumatoid Arthritis-Associated Interstitial Lung Disease

Vanessa Kronzer1, Yangyuna Yang2, Punyasha Roul3, James Crooks4, Cynthia Crowson1, John Davis1, Jeffrey Sparks5, Jeffrey Pierce6, Katelyn O'Dell7, Sauer brian8, grant Cannon9, Joshua Baker10, Ted Mikuls2 and Bryant England2, 1Mayo Clinic, Rochester, MN, 2University of Nebraska Medical Center, Omaha, NE, 3UNMC, Omaha, NE, 4National Jewish Health, Denver, 5Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA, Boston, MA, 6Colorado State University, Fort Collins, 7George Washington University, Washington DC, 8Salt Lake City VA/University of Utah, Salt Lake City, UT, 9University of Utah and Salt Lake City VA, Salt Lake City, UT, 10Department of Medicine, Perelman School of Medicine University of Pennsylvania, Philadelphia, PA

Meeting: ACR Convergence 2024

Keywords: Environmental factors, Epidemiology, interstitial lung disease, rheumatoid arthritis, Smoking

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, November 17, 2024

Title: Epidemiology & Public Health Poster II

Session Type: Poster Session B

Session Time: 10:30AM-12:30PM

Background/Purpose: Wildfires have burned increasing acreage in the United States (US) since the 1980s, releasing record and alarming levels of particulate matter smaller than 2.5 microns (PM2.5,). In addition, respiratory tract irritation is associated with rheumatoid arthritis (RA). Therefore, we aimed (1) to determine the associations between fire smoke PM2.5 and other pollutant exposures with the risk of RA and RA-associated interstitial lung disease (RA-ILD) and (2) to identify the timing of any such associations.

Methods: In this case-control study using national Veterans Affairs (VA) data, we identified incident RA and RA-ILD cases using validated algorithms (positive predictive values >90% and 81%, respectively). We matched each case to up to 10 controls on age, gender, and VA enrollment year. Seropositivity was based on electronic health record laboratory data. The primary exposure was mean daily fire smoke PM2.5 at least one year before RA diagnosis, obtained from a fused product of ground pollutant monitoring and satellite imagery. Other pollutants included carbon monoxide, nitrogen oxides (NOx), ozone, overall PM2.5, PM10, and sulfur dioxide (SO2). Pollutant exposures were also evaluated by time periods before RA (1-3 years, 3-5 years, >5 years). We used conditional logistic regression models to estimate adjusted odds ratios (aOR) with 95% confidence intervals (CI) for incident RA and RA-ILD, adjusted for age, gender, enrollment year, duration of pollutant exposures, race and ethnicity, body mass index, and smoking status.

Results: We identified 9,701 incident RA cases (mean age 65, 86% male), including 531 RA-ILD cases (mean age 69, 91% male), and 68,852 matched controls (Table 1). Fire smoke PM2.5 was not associated with RA overall (aOR 1.07, 95% CI 0.92-1.23, Table 2), but was associated in the 1-5 years before RA onset (aOR 1.13, 95% CI 1.02-1.26, Figure 1). Fire smoke PM2.5 was associated with RA-ILD (aOR 1.98, 95% CI 1.08-3.62 per 1 µg/m3). Increased levels of NOx were also associated with RA (aOR 1.16, 95% CI 1.06-1.27 for highest vs. lowest quartile, Table 2). Ozone (aOR 1.19, 95% CI 1.06-1.34) and PM10 (aOR 1.25, 95% CI 1.10-1.43) were associated with seronegative, but not seropositive, RA. Carbon monoxide, overall PM2.5, and SO2 were not, or negatively, associated with risk of RA and RA-ILD (Table 2).

Conclusion: Increased levels of fire smoke PM2.5 are associated with RA-ILD, while fossil fuel-related NOx, ozone, and PM10 are associated with RA. Therefore, improved pollutant monitoring infrastructure and prevention strategies are needed.

Supporting image 1

Supporting image 2

Supporting image 3

Figure 1. Forest plot depicting associations of fire smoke PM2.5 with risk of RA by exposure time period. Models are per 1 µg/m3 increase in PM2.5 and adjusted for age, sex, enrollment, duration of pollutant exposure data, race and ethnicity, body mass index, and smoking status. RA = rheumatoid arthritis.

Disclosures: V. Kronzer: None; Y. Yang: None; P. Roul: None; J. Crooks: None; C. Crowson: None; J. Davis: Girihlet, 10, NLC Health Ventures, 10, Pfizer, 5, Remission Medical, 10; J. Sparks: Boehringer-Ingelheim, 2, 5, Bristol-Myers Squibb(BMS), 2, 5, Gilead, 2, Janssen, 2, Pfizer, 2, UCB, 2; J. Pierce: None; K. O'Dell: None; S. brian: None; g. Cannon: None; J. Baker: CorEvitas, LLC, 2, Cumberland Pharma, 2, Formation Bio, 2, Horizon, 5; T. Mikuls: Elsevier, 9, Horizon Therapeutics, 2, 5, Pfizer, 2, Sanofi, 2, UCB Pharma, 2, Wolters Kluwer Health (UpToDate), 9; B. England: Boehringer-Ingelheim, 5.

To cite this abstract in AMA style:

Kronzer V, Yang Y, Roul P, Crooks J, Crowson C, Davis J, Sparks J, Pierce J, O'Dell K, brian S, Cannon g, Baker J, Mikuls T, England B. Associations of Fire Smoke and Other Pollutants with Incident Rheumatoid Arthritis and Rheumatoid Arthritis-Associated Interstitial Lung Disease [abstract]. Arthritis Rheumatol. 2024; 76 (suppl 9). https://acrabstracts.org/abstract/associations-of-fire-smoke-and-other-pollutants-with-incident-rheumatoid-arthritis-and-rheumatoid-arthritis-associated-interstitial-lung-disease/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2024

ACR Meeting Abstracts - https://acrabstracts.org/abstract/associations-of-fire-smoke-and-other-pollutants-with-incident-rheumatoid-arthritis-and-rheumatoid-arthritis-associated-interstitial-lung-disease/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology